Zobrazeno 1 - 10
of 218
pro vyhledávání: '"Keith C. Meyer"'
Autor:
Ganesh Raghu, Mark J. Hamblin, A. Whitney Brown, Jeffrey A. Golden, Lawrence A. Ho, Marlies S. Wijsenbeek, Martina Vasakova, Alberto Pesci, Danielle E. Antin-Ozerkis, Keith C. Meyer, Michael Kreuter, Tracy Burgess, Nikhil Kamath, Francis Donaldson, Luca Richeldi
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-12 (2022)
Abstract Background Recombinant human pentraxin-2 (rhPTX-2) significantly decreased decline in percent predicted forced vital capacity (FVC) and stabilized 6-min walk distance (6MWD) in patients with idiopathic pulmonary fibrosis (IPF) during the 28-
Externí odkaz:
https://doaj.org/article/2c195c019cfe4de6992fd1e22d59cc6f
Autor:
Francis H. C. Tsao, Keith C. Meyer
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 19, p 11675 (2022)
Age-dependent conformational stability of human serum albumin was determined by the method of fluorescent bilayer liposome assay. After pre-heating at 80 °C, albumin in the sera of 74-year-old healthy subjects exhibited hydrophobic effects on liposo
Externí odkaz:
https://doaj.org/article/a38aad6197e4427fa303c70f05b3ee03
Autor:
Ganesh Raghu, Keith C. Meyer
Publikováno v:
European Respiratory Review, Vol 30, Iss 161 (2021)
Organising pneumonia (OP) is currently recognised as a nonspecific lung injury response that is associated with a variety of imaging patterns obtained with high-resolution computed tomography (HRCT) of the chest and is characterised histopathological
Externí odkaz:
https://doaj.org/article/75861faae19f4a0db6cab6107f8c80d0
Autor:
Robert Kim, Keith C. Meyer
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 2 (2008)
As our understanding of the pathobiology and natural history of the various forms of interstitial lung disease (ILD) has evolved, so have our approaches to treating this heterogeneous group of lung disorders. The earliest pharmacologic agents used to
Externí odkaz:
https://doaj.org/article/a29ea8f365ae4dedaa07bd8bac8f21ae
Autor:
Gerald J. Berry, Daniel F. Dilling, Sofya Tokman, Aida Venado, Heather M. Strah, Tanya McWilliams, Vaidehi Kaza, Brad Bemiss, Marie Budev, Arun Nair, Katharina Wassilew, Sangeeta Bhorade, Rupal J. Shah, Hilary J. Goldberg, M. Howsare, Erika D. Lease, Michelle Murray, Amparo Solé, Cynthia J. Gries, Keith C. Meyer, Juan C Salgado, Carol Farver, Caroline M. Patterson, Are Martin Holm, Nora Sandorfi, Maria M. Crespo, Keith Willie, Jérôme Le Pavec, José M. Cifrián, Laurie D. Snyder, Osnat Shtraichman
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:1251-1266
Patients with connective tissue disease (CTD) and advanced lung disease are often considered suboptimal candidates for lung transplantation (LTx) due to their underlying medical complexity and potential surgical risk. There is substantial variability
Autor:
Ganesh Raghu, Mark J. Hamblin, A. Whitney Brown, Jeffrey A. Golden, Lawrence A. Ho, Marlies S. Wijsenbeek, Martina Vasakova, Alberto Pesci, Danielle E. Antin-Ozerkis, Keith C. Meyer, Michael Kreuter, Tracy Burgess, Nikhil Kamath, Francis Donaldson, Luca Richeldi
Publikováno v:
Respiratory Research, 23(1):129. BioMed Central Ltd.
Background Recombinant human pentraxin-2 (rhPTX-2) significantly decreased decline in percent predicted forced vital capacity (FVC) and stabilized 6-min walk distance (6MWD) in patients with idiopathic pulmonary fibrosis (IPF) during the 28-week, pla
Autor:
Keith C. Meyer
Publikováno v:
The Lancet Respiratory Medicine
The Lancet. Respiratory Medicine
The Lancet. Respiratory Medicine
Publikováno v:
Journal of Alzheimer's Disease Reports
Aging-related protein misfolding and aggregation may play critical roles in the pathogenesis of numerous diseases. In the brain, extracellular aggregated amyloid-β (Aβ) is closely related to the death of neurons in individuals with Alzheimer’s di
Autor:
Keith C. Meyer, Robin K. Avery
Publikováno v:
American Journal of Transplantation
Vaccine-preventable viral infections are associated with increased risk of morbidity and mortality in post-transplant patients on immunosuppression regimens. Therefore, we studied rates of immunity against vaccine-preventable viruses in lung transpla
Autor:
A. Whitney Brown, Renu Gupta, Ganesh Raghu, Luca Richeldi, Mark J. Hamblin, Lawrence A. Ho, Marlies S. Wijsenbeek, Bernt van den Blink, Jeffrey A. Golden, Hugues Santin-Janin, Michael Kreuter, Geert-Jan Mulder, Martina Vasakova, Danielle Antin-Ozerkis, Francois Aubin, Keith C. Meyer, Donna Moran, Alberto Pesci
Publikováno v:
The Lancet Respiratory Medicine, 7(8), 657-664. Elsevier Ltd.
Background: Patients with idiopathic pulmonary fibrosis (IPF) treated with PRM-151, a recombinant human pentraxin 2 protein, in a phase 2 double-blind, randomised controlled trial had significantly reduced decline in percentage of predicted forced vi